Immunity. 2006 Sep;25(3):383-92.

Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Source

Baylor Institute for Immmunology Research, 3434 Live Oak, Dallas, Texas 75204, USA. jacquesb@baylorhealth.edu

Abstract

Different genetic alterations may lead to type I interferon (IFN) overproduction in human systemic lupus erythematosus (SLE). The increased bioavailability of type I IFN contributes to peripheral tolerance breakdown through the activation of immature myeloid dendritic cells (mDCs). IFN-matured mDCs activate autoreactive T cells. These cells, together with plasmacytoid DCs, help expand autoreactive B cells. IFN-matured DCs also activate cytotoxic CD8+ T cells, possibly increasing apoptotic cell availability. The capture of apoptotic cells by mDCs and of nucleic acid-containing immune complexes by plasmacytoid DCs and B cells amplifies the autoimmune reaction leading to disease manifestations. Genetic alterations in lineages other than B cells might explain other autoimmune syndromes where type I IFNs appear to be involved.

PMID:: 16979570; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Interferon Type I

Grant Support

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Review A compass that points to lupus: genetic studies on type I interferon pathway. [Genes Immun. 2007]
Review A compass that points to lupus: genetic studies on type I interferon pathway.
Kyogoku C, Tsuchiya N. Genes Immun. 2007 Sep; 8(6):445-55. Epub 2007 Jun 21.
Review Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus. [Ann N Y Acad Sci. 2007]
Review Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
Mangini AJ, Lafyatis R, Van Seventer JM. Ann N Y Acad Sci. 2007 Jun; 1108:11-23.
Review An etiopathogenic role for the type I IFN system in SLE. [Trends Immunol. 2001]
Review An etiopathogenic role for the type I IFN system in SLE.
Rönnblom L, Alm GV. Trends Immunol. 2001 Aug; 22(8):427-31.
Review Systemic lupus erythematosus: all roads lead to type I interferons. [Curr Opin Immunol. 2006]
Review Systemic lupus erythematosus: all roads lead to type I interferons.
Pascual V, Farkas L, Banchereau J. Curr Opin Immunol. 2006 Dec; 18(6):676-82. Epub 2006 Oct 2.
Review Type I interferon in systemic lupus erythematosus. [Curr Top Microbiol Immunol. 2007]
Review Type I interferon in systemic lupus erythematosus.
Crow MK. Curr Top Microbiol Immunol. 2007; 316:359-86.

See reviews... See all...

Cited by 90 PubMed Central articles

Stochastic Expression of the Interferon-β Gene. [PLoS Biol. 2012]
Stochastic Expression of the Interferon-β Gene.
Zhao M, Zhang J, Phatnani H, Scheu S, Maniatis T. PLoS Biol. 2012 Jan; 10(1):e1001249. Epub 2012 Jan 24.
Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis. [Int J Rheumatol. 2011]
Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis.
de Oliveira DB, Almeida GM, Guedes AC, Santos FP, Bonjardim CA, Ferreira PC, Kroon EG. Int J Rheumatol. 2011; 2011:275617. Epub 2011 Nov 1.
Exhausted cytotoxic control of Epstein-Barr virus in human lupus. [PLoS Pathog. 2011]
Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, et al. PLoS Pathog. 2011 Oct; 7(10):e1002328. Epub 2011 Oct 20.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
Immunity. 2006 Sep ;25(3):383-92.

PubMed
Interleukin (IL)-22, a novel human cytokine that signals through the interferon ...
Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R.
J Biol Chem. 2000 Oct 6 ;275(40):31335-9.

PubMed
Involvement of matrix metalloproteinases and their inhibitors in peripheral syno...
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Arthritis Rheum. 2004 Sep ;50(9):2942-53.

PubMed
Prevalence of self-reported arthritis or chronic joint symptoms among adults--Un...
Prevalence of self-reported arthritis or chronic joint symptoms among adults--United States, 2001.
MMWR Morb Mortal Wkly Rep. 2002 Oct 25 ;51(42):948-50.

PubMed
Early predictors of poor functional outcome in systemic-onset juvenile rheumatoi...
Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.
Arthritis Rheum. 2000 Nov ;43(11):2402-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

Supplemental Content

Related citations

Cited by 90 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information